These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 19685521

  • 41. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 42. Stroke prevention in patients with non-valvular atrial fibrillation: new insight in selection of rhythm or rate control therapy and impact of mean platelet volume.
    Hong SP, Choi DH, Kim HW, Kim BB, Chung JW, Koh YY, Chang KS.
    Curr Pharm Des; 2013 Apr; 19(32):5824-9. PubMed ID: 23713815
    [Abstract] [Full Text] [Related]

  • 43. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
    Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH.
    Thromb Haemost; 2017 Oct 05; 117(10):1848-1858. PubMed ID: 28799620
    [Abstract] [Full Text] [Related]

  • 44. Significance of recurrences of new atrial fibrillation in acute myocardial infarction.
    Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, Vojvodic A, Marinkovic J, Ostojic M, Vasiljevic Z.
    Int J Cardiol; 2006 May 10; 109(2):235-40. PubMed ID: 16005995
    [Abstract] [Full Text] [Related]

  • 45. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX, Malo S, Svenson LW, Wilton SB, Hill MD.
    J Am Heart Assoc; 2017 Oct 28; 6(11):. PubMed ID: 29080863
    [Abstract] [Full Text] [Related]

  • 46. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K.
    Age Ageing; 2005 Jan 28; 34(1):35-40. PubMed ID: 15591481
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Postoperative Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery Predicts Long-Term Atrial Fibrillation and Stroke.
    Konstantino Y, Zelnik Yovel D, Friger MD, Sahar G, Knyazer B, Amit G.
    Isr Med Assoc J; 2016 Dec 28; 18(12):744-748. PubMed ID: 28457078
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.
    Schmitt J, Duray G, Gersh BJ, Hohnloser SH.
    Eur Heart J; 2009 May 28; 30(9):1038-45. PubMed ID: 19109347
    [Abstract] [Full Text] [Related]

  • 56. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP.
    Platelets; 2011 May 28; 22(6):408-14. PubMed ID: 21599611
    [Abstract] [Full Text] [Related]

  • 57. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI, Hart R, Pearce LA.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD006186. PubMed ID: 17636831
    [Abstract] [Full Text] [Related]

  • 58. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
    Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB.
    Eur Heart J; 2009 Aug 18; 30(16):2019-28. PubMed ID: 19502623
    [Abstract] [Full Text] [Related]

  • 59. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.
    Yao X, Gersh BJ, Sangaralingham LR, Shah ND, Noseworthy PA.
    Am Heart J; 2018 May 18; 199():137-143. PubMed ID: 29754652
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.